It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
MicroRNAs are an emerging class of synaptic regulators. These small noncoding RNAs post-transcriptionally regulate gene expression, thereby altering neuronal pathways and shaping cell-to-cell communication. Their ability to rapidly alter gene expression and target multiple pathways makes them interesting candidates in the study of synaptic plasticity. Here, we demonstrate that the proconvulsive microRNA miR-324-5p regulates excitatory synapse structure and function in the hippocampus of mice. Both Mir324 knockout (KO) and miR-324-5p antagomir treatment significantly reduce dendritic spine density in the hippocampal CA1 subregion, and Mir324 KO, but not miR-324-5p antagomir treatment, shift dendritic spine morphology, reducing the proportion of thin, “unstable” spines. Western blot and quantitative Real-Time PCR revealed changes in protein and mRNA levels for potassium channels, cytoskeletal components, and synaptic markers, including MAP2 and Kv4.2, which are important for long-term potentiation (LTP). In line with these findings, slice electrophysiology revealed that LTP is severely impaired in Mir324 KO mice, while neurotransmitter release probability remains unchanged. Overall, this study demonstrates that miR-324-5p regulates dendritic spine density, morphology, and plasticity in the hippocampus, potentially via multiple cytoskeletal and synaptic modulators.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of Cincinnati Neuroscience Graduate Program, Cincinnati, USA (GRID:grid.24827.3b) (ISNI:0000 0001 2179 9593); Cincinnati Children’s Hospital Medical Center, Division of Neurology, Cincinnati, USA (GRID:grid.239573.9) (ISNI:0000 0000 9025 8099)
2 The University of Texas at Austin, Center for Learning and Memory, Department of Neuroscience, Austin, USA (GRID:grid.89336.37) (ISNI:0000 0004 1936 9924)
3 Cincinnati Children’s Hospital Medical Center, Division of Neurology, Cincinnati, USA (GRID:grid.239573.9) (ISNI:0000 0000 9025 8099)
4 University of Cincinnati Neuroscience Graduate Program, Cincinnati, USA (GRID:grid.24827.3b) (ISNI:0000 0001 2179 9593); Cincinnati Children’s Hospital Medical Center, Division of Neurology, Cincinnati, USA (GRID:grid.239573.9) (ISNI:0000 0000 9025 8099); University of Cincinnati College of Medicine, Department of Pediatrics, Cincinnati, USA (GRID:grid.24827.3b) (ISNI:0000 0001 2179 9593)
5 University of Cincinnati College of Medicine, Department of Pediatrics, Cincinnati, USA (GRID:grid.24827.3b) (ISNI:0000 0001 2179 9593); Cincinnati Children’s Hospital Medical Center, Transgenic Animal and Genome Editing Core Facility, Cincinnati, USA (GRID:grid.239573.9) (ISNI:0000 0000 9025 8099); Cincinnati Children’s Hospital Medical Center, Division of Developmental Biology, Cincinnati, USA (GRID:grid.239573.9) (ISNI:0000 0000 9025 8099)